Determination of Cell Proliferation Using Mcm2 Antigen and Evaluation of Apoptosis and TGF-β1 Expression in GH-secreting or Clinically Nonfunctioning Pituitary Adenomas

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Endocrine pathology

• Publication date

  2010-02-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12022-010-9107-xPMID 20174894
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Significance of MCM-2 and MCM-5 Expression in Colon Cancer: Association with Clinicopathological Parameters and Tumor Proliferative Capacity

  2009cited by this paper
• Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas.

  2008cited by this paper
• Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas.

  2008cited by this paper
• Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.

  2008cited by this paper
• Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications

  2007cited by this paper
• Mcm‐2 and Ki‐67 Have Limited Potential in Preoperative Diagnosis of Thyroid Malignancy

  2006cited by this paper
• Mitogenic effects of the up-regulation of minichromosome maintenance proteins in anaplastic thyroid carcinoma.

  2005cited by this paper
• Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.

  2005cited by this paper
• The correlation of Ki-67 staining indices with tumour doubling times in regrowing non-functioning pituitary adenomas

  2005cited by this paper
• Clinical Significance of Ki-67 Labeling Index in Pituitary Macroadenoma

  2005cited by this paper
• Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody.

  2004influential reference
• Correlation of Bcl-2 and Bax with Apoptosis in Human Pituitary Adenomas

  2004cited by this paper
• Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase α monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts

  2004cited by this paper
• Intrapituitary Regulatory System of Proliferation of Mammotrophs in the Pituitary Gland

  2004cited by this paper
• Minichromosome maintenance 2 expression is correlated with mode of invasion and prognosis in oral squamous cell carcinomas.

  2003cited by this paper
• Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer.

  2003cited by this paper
• A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma

  2003cited by this paper
• Expression of Ki-67 antigen in nonfunctioning pituitary adenomas: correlation with growth velocity and invasiveness.

  2003cited by this paper
• Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index.

  2003cited by this paper
• A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomas.

  2002cited by this paper
• MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer.

  2001cited by this paper
• Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer.

  2001cited by this paper
• Lack of correlation between Ki-67 labelling index and tumor size of anterior pituitary adenomas

  2001cited by this paper
• Effects of octreotide treatment on the proliferation and apoptotic index of GH-secreting pituitary adenomas.

  2001cited by this paper
• The Role of Hormones, Growth Factors and Their Receptors in Pituitary Tumorigenesis

  2001cited by this paper
• Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors : comparison between micro- and macroadenomas.

  2000cited by this paper
• Apoptosis in nontumorous and neoplastic human pituitaries: expression of the Bcl-2 family of proteins.

  1999cited by this paper
• Are Markers of Proliferation Valuable in the Histological Assessment of Pituitary Tumours?

  1999cited by this paper
• Proliferation Markers in Different Types of Clinically Non-Secreting Pituitary Adenomas

  1999cited by this paper
• Usefulness of markers of cell proliferation in the management of pituitary adenomas.

  1998cited by this paper
• Tumor growth and biological markers in pituitary adenomas

  1998cited by this paper
• The cytogenesis and pathogenesis of pituitary adenomas.

  1998cited by this paper
• Apoptosis in human pituitary adenomas: a morphologic and in situ end-labeling study.

  1997cited by this paper
• Apoptosis and p53 suppressor gene protein expression in human anterior pituitary adenomas.

  1997influential reference
• Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.

  1997cited by this paper
• Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody.

  1996influential reference
• Biologic markers of invasive pituitary adenomas involving the sphenoid sinus.

  1995cited by this paper
• Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67.

  1989cited by this paper
• Growth rate of human pituitary adenomas.

  1987influential reference
• Tumours

  1916cited by this paper

• Prenatal p25-activated Cdk5 induces pituitary tumorigenesis through MCM2 phosphorylation-mediated cell proliferation

  2024cites this paper
• Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways

  2023cites this paper
• Quantitative proteomics revealed the molecular characteristics of distinct types of granulated somatotroph adenomas

  2021cites this paper
• PTTG overexpression in non-functioning pituitary adenomas: Correlation with invasiveness, female gender and younger age.

  2019cites this paper
• Association of TGF-β1 and WIF1 Expression with 36 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas: A High-Throughput Tissue Microarrays Immunohistochemical Study.

  2018cites this paper
• Aberrant expression of MCM 2 and Ki-67 are associated with endometrial carcinoma and its survival rate

  2018cites this paper
• In sickness and in health: The many roles of the minichromosome maintenance proteins.

  2017cites this paper
• Caracterización del sistema TGF-ß1 hipofisario: en búsqueda de un blanco terapéutico para prolactinomas resistentes a agonistas dopaminérgicos

  2012cites this paper
• Ki-67 and minichromosome maintenance-7 (MCM7) expression in canine pituitary corticotroph adenomas.

  2011cites this paper